When was Lyka Labs founded?

Lyka Labs was founded in 1976 and raised its 1st funding round 39 years after it was founded.

Where is Lyka Labs located?

Lyka Labs is headquartered in Mumbai, India. It is registered at 4801/B & 4802/A GIDC INDUTRAIL ESTATE, ANKLESHWAR, Gujarat, India, 393002.

How many employees does Lyka Labs have?

As of Sep 30, 2026, the latest employee count at Lyka Labs is 421.

Is Lyka Labs a funded company?

Lyka Labs is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Dec 28, 2015.

When was the latest funding round of Lyka Labs?

Lyka Labs' latest funding was a $***** Post IPO round on Nov 24, 2021, with participation from 1 investor. Its primary sector is Traditional Pharmaceuticals. In India, the Traditional Pharmaceuticals sector has seen $800M in funding in 2026 to date.

What is the annual revenue of Lyka Labs?

Annual revenue of Lyka Labs is between ₹100 Cr and ₹500 Cr as on Mar 31, 2025

Where does Lyka Labs rank among its competitors?

Lyka Labs ranks 352nd amongst 1239 active competitors, of which 43 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Lyka Labs?

Lyka Labs' top competitors include Bayer, Teva Pharmaceuticals and Wockhardt. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Lyka Labs - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Website: lykalabs.com
Social
Email ID: *****@lykalabs.com
Phone Number: +91 **********
Registered Address: 4801/B & 4802/A GIDC INDUTRAIL ESTATE, ANKLESHWAR, Gujarat, India, 393002

Key Metrics

Founded Year

1976

Location

Mumbai, India

Stage

Public

Latest Funding Round

Post IPO, Nov 24, 2021, $*****

Investors

Ipca Laboratories

Ranked

352^nd among 1239 active competitors

Annual Revenue

₹100 - ₹500 Cr as on Mar 31, 2025

Employee Count

421 as on Sep 30, 2026

Similar Companies

Teva Pharmaceuticals & 1463 more

Exit Details

Public

View Lyka Labs' full profile

Lyka Labs is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
LYKA BDR INTERNATIONAL LIMITED CIN: U24234MH1993PLC072947 , India, Active	Jul 19, 1993	0 - ₹10 Cr (As on Mar 31, 2025)	2 (As on Mar 31, 2024)
Lyka Exports Limited CIN: U51100GJ1992PLC023975 , India, Active	Dec 04, 1992	0 - ₹10 Cr (As on Mar 31, 2025)	1 (As on May 31, 2023)
LYKA LABS LIMITED CIN: L24230GJ1976PLC008738 , India, Active	Dec 29, 1976	₹100 - ₹500 Cr (As on Mar 31, 2025)	422 (As on Jun 30, 2024)

Lyka Labs got listed on Feb 08, 1995.

Click here to take a look at Lyka Labs's IPO in detail

Lyka Labs has raised funding over 2 rounds. Its first funding round was on Dec 28, 2015. Its latest funding round was a Post IPO round on Nov 24, 2021 for $*****. 1 investor participated in its latest round. Lyka Labs has 1 institutional investor.

Here is the list of recent funding rounds of Lyka Labs:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 24, 2021	4476563	Post IPO	7501072	2980791	8283591	9577735
Dec 28, 2015	1633970	Post IPO	2277805	5274393	5877314	4769650

Access funding benchmarks and valuations. Sign up today!

View details of Lyka Labs's funding rounds and investors

Lyka Labs' employee count trend

Lyka Labs has 421 employees as of Sep 26. Here is Lyka Labs's employee count trend over the years:

Uncover Lyka Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lyka Labs include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Lyka Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
5th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
6th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
7th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
8th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
9th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
10th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100
352nd	Lyka Labs 1976, Mumbai (India), Public	Manufacturer of pharmaceutical formulations and APIs	-	Ipca Laboratories	37/100